These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38733475)

  • 1. Personalized venlafaxine dose prediction using artificial intelligence technology: a retrospective analysis based on real-world data.
    Liu Y; Yu Z; Ye X; Zhang J; Hao X; Gao F; Yu J; Zhou C
    Int J Clin Pharm; 2024 Aug; 46(4):926-936. PubMed ID: 38733475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence.
    Chang L; Hao X; Yu J; Zhang J; Liu Y; Ye X; Yu Z; Gao F; Pang X; Zhou C
    Int J Clin Pharm; 2024 Aug; 46(4):899-909. PubMed ID: 38753076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence-based model for dose prediction of sertraline in adolescents: a real-world study.
    Fu R; Yu Z; Zhou C; Zhang J; Gao F; Wang D; Hao X; Pang X; Yu J
    Expert Rev Clin Pharmacol; 2024; 17(2):177-187. PubMed ID: 38197873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study.
    Yu Z; Ye X; Liu H; Li H; Hao X; Zhang J; Kou F; Wang Z; Wei H; Gao F; Zhai Q
    Front Oncol; 2022; 12():893966. PubMed ID: 35719963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based prediction of sertraline concentration in patients with depression through therapeutic drug monitoring.
    Fu R; Hao X; Yu J; Wang D; Zhang J; Yu Z; Gao F; Zhou C
    Front Pharmacol; 2024; 15():1289673. PubMed ID: 38510645
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting quetiapine dose in patients with depression using machine learning techniques based on real-world evidence.
    Hao Y; Zhang J; Yu J; Yu Z; Yang L; Hao X; Gao F; Zhou C
    Ann Gen Psychiatry; 2024 Jan; 23(1):5. PubMed ID: 38184628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
    Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E
    Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring of Venlafaxine in an Everyday Clinical Setting: Analysis of Age, Sex and Dose Concentration Relationships.
    Hansen MR; Kuhlmann IB; Pottegård A; Damkier P
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):298-302. PubMed ID: 28397349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression.
    Hole K; Arnestad M; Molden E; Haslemo T
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):281-285. PubMed ID: 33905640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
    Benkert O; Gründer G; Wetzel H; Hackett D
    J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality.
    Lessing C; Ashton T; Davis P
    Value Health; 2015 Jul; 18(5):646-54. PubMed ID: 26297093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
    Ivanets NN; Kinkulkina MA; Tikhonova YG; Iziumina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):30-34. PubMed ID: 25909786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.
    Monfared AA; Han D; Sheehy O; Bexton B; Lelorier J
    Curr Med Res Opin; 2006 Jan; 22(1):83-94. PubMed ID: 16393434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior.
    Alvarez Silva A; Fernández-Guasti A
    Pharmacol Biochem Behav; 2019 Dec; 187():172817. PubMed ID: 31655085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques.
    Zheng P; Yu Z; Mo L; Zhang Y; Lyu C; Yu Y; Zhang J; Hao X; Wei H; Gao F; Li Y
    Front Pharmacol; 2022; 13():890221. PubMed ID: 36339624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
    Rej S; Dew MA; Karp JF
    Pain Med; 2014 Jul; 15(7):1154-62. PubMed ID: 25040462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and internal validation of machine learning models for personalized survival predictions in spinal cord glioma patients.
    Karabacak M; Schupper AJ; Carr MT; Bhimani AD; Steinberger J; Margetis K
    Spine J; 2024 Jun; 24(6):1065-1076. PubMed ID: 38365005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A machine learning model for predicting blood concentration of quetiapine in patients with schizophrenia and depression based on real-world data.
    Hao Y; Zhang J; Yang L; Zhou C; Yu Z; Gao F; Hao X; Pang X; Yu J
    Br J Clin Pharmacol; 2023 Sep; 89(9):2714-2725. PubMed ID: 37005382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.